Company logo

MannKind | Sustainability Performance

https://www.mannkindcorp.com

Develops and commercializes therapeutic products for diseases such as diabetes and pulmonary conditions. Focuses on innovative drug delivery systems and improving patient care.

1991

United States

201 - 500 employees

Pharmaceuticals

$100M - 500M in revenue

Not profitable

Sustainability Ranking & Industry Benchmark

#4508
Overall
#903
in United States
#97
in Pharmaceuticals

Sustainability Maturity


Sustainability Intent

Available in
Scale package

Access

Industry Rank

129 out of 287

Market cap Total market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
1.1B$, 2026
Revenue Total revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
348.0M$, 202518.1% YoY
R&D intensity Research and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.
18.97%2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees

We follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.


    Available in
    Scale package

    Access